BioCentury | Dec 20, 2010
Company News

Inimex, SARomics Biostructures AB, Vectron Biosolutions A/S deal

...SARomics and Vectron Biosolutions received an undisclosed milestone payment from Inimex under a 2009 deal to...
...were not disclosed. Inimex Pharmaceuticals Inc. , Burnaby, B.C. SARomics Biostructures AB , Lund, Sweden Vectron...
BioCentury | Jan 3, 2005
Company News

Pharmexa, vectron deal

...PHARMX acquired rights to Vectron's IP covering targeted liposomal delivery systems and single-chain diabodies, which are...
...diabodies, which are recombinant antibody-like proteins that PHARMX said can be used for passive immunotherapy. Vectron...
...filed for insolvency in 2004 and is liquidating its assets. Pharmexa A/S (CSE:PHARMX), Horsholm, Denmark Vectron Therapeutics AG...
BioCentury | Jun 1, 2004
Company News

Vectron on the block

...German cancer play Vectron (Marburg, Germany) filed for insolvency on Tuesday, and said its drug delivery...
BioCentury | Nov 24, 2003
Company News

vectron management update

vectron therapeutics AG , Marburg, Germany Business: Cancer Hired: Petra Wuelfroth as CEO, formerly president of International Pharma Consulting; Axel Leimer as CBO, formerly president of Leimer Biotech Strategy Consulting WIR Staff cancer...
BioCentury | Nov 17, 2003
Company News

vectron hires Wuelfroth as CEO

...Cancer company vectron (Marburg, Germany) hired Petra Wuelfroth as CEO. Previously, she was founder and president...
...hired Petra Wuelfroth as CEO. Previously, she was founder and president for International Pharma Consulting. vectron...
BioCentury | Aug 4, 2003
Strategy

Clinical leaders

...U.K. ThromboGenics Ph II Ireland Transgene (NM:Transgene; TRGNY) Ph II France Trigen Ph II U.K. Vectron...
Items per page:
1 - 6 of 6
BioCentury | Dec 20, 2010
Company News

Inimex, SARomics Biostructures AB, Vectron Biosolutions A/S deal

...SARomics and Vectron Biosolutions received an undisclosed milestone payment from Inimex under a 2009 deal to...
...were not disclosed. Inimex Pharmaceuticals Inc. , Burnaby, B.C. SARomics Biostructures AB , Lund, Sweden Vectron...
BioCentury | Jan 3, 2005
Company News

Pharmexa, vectron deal

...PHARMX acquired rights to Vectron's IP covering targeted liposomal delivery systems and single-chain diabodies, which are...
...diabodies, which are recombinant antibody-like proteins that PHARMX said can be used for passive immunotherapy. Vectron...
...filed for insolvency in 2004 and is liquidating its assets. Pharmexa A/S (CSE:PHARMX), Horsholm, Denmark Vectron Therapeutics AG...
BioCentury | Jun 1, 2004
Company News

Vectron on the block

...German cancer play Vectron (Marburg, Germany) filed for insolvency on Tuesday, and said its drug delivery...
BioCentury | Nov 24, 2003
Company News

vectron management update

vectron therapeutics AG , Marburg, Germany Business: Cancer Hired: Petra Wuelfroth as CEO, formerly president of International Pharma Consulting; Axel Leimer as CBO, formerly president of Leimer Biotech Strategy Consulting WIR Staff cancer...
BioCentury | Nov 17, 2003
Company News

vectron hires Wuelfroth as CEO

...Cancer company vectron (Marburg, Germany) hired Petra Wuelfroth as CEO. Previously, she was founder and president...
...hired Petra Wuelfroth as CEO. Previously, she was founder and president for International Pharma Consulting. vectron...
BioCentury | Aug 4, 2003
Strategy

Clinical leaders

...U.K. ThromboGenics Ph II Ireland Transgene (NM:Transgene; TRGNY) Ph II France Trigen Ph II U.K. Vectron...
Items per page:
1 - 6 of 6